Metformin for Long COVID
In this study, researchers demonstrated that the use of metformin within the first four days of COVID-19 symptoms reduced healthcare utilization and the incidence of long COVID. The researchers write: “In conclusion, early outpatient COVID-19 treatment with metformin decreased the subsequent risk of long COVID by 41.3% during 10-month follow-up. This finding is consistent with the 42.3% reduction in healthcare utilization for severe COVID-19 with metformin in the first 14 days of the trial.”
Make a Donation
FLCCC is dedicated to educating as many healthcare providers as possible across the globe and empowering patients with Long COVID or post vaccine injuries to take control of their own health. To help us continue this work, please consider donating to help us cover the costs of these conferences. For other donation options please visit our Donate page!
